Tags |
|
|
Links |
|
|
Advice You - Franchising the World will Never Work Say Critics
Many critics and critical thinkers think that Franchising the Wor
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ld cannot work, but it already kind of is. Oh, these critics have
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
all sorts of silly notions as to why it will not work such as; it
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
is too complicated. Or franchising Nations and Nation States is t
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
o complicated. They say it is much more complicated than franchis
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ng a Burger Joint and leave all the hard work to us?
Sure leave
Sure leave
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
t to them and the United Nations huh? What on Earth are they talk
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ing about? These same critics cannot hit anything but a slow ball
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
and they cannot exactly hit it out of the park. I mean would you
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ook at the Middle East issues, Africa AIDS issues, Communism on t
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
e rise in South America and gigantic emerging nations of China an
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
India and all those disruptive issues to World Civilization, tra
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
e, interdependent economics and such?
Still the critics think th
Still the critics think th
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
y know best and that Franchising the World will Never work they s
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ay. Yet we have already franchised nations; Look at the EU Model?
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
Surely this will happen again; separate countries working togethe
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
in a framework of an over all system. Looks very similar to a fr
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
nchise to me. Although it is not working perfectly due to some of
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
the nations being socialist countries and severely deficit spendi
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
g; it is working better than anything else. Consider this in 2006
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/19315/adviceyou-Franchising-the-World-will-Never-Work-Say-Critics.html">Franchising the World will Never Work Say Critics</a>
BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/19315/adviceyou-Franchising-the-World-will-Never-Work-Say-Critics.html]Franchising the World will Never Work Say Critics[/url]
Related Articles:
Innovation Expenses - Finding the Right Balance
Understanding an SES Federal Government Job and How to Apply
Arbitration - Saves Time and Expense!
Bookmark it:
|